Biosimilars of anti-vascular endothelial growth factor for ophthalmic diseases: A review

2024/03/21 by Neil M. Bressler, Peter K. Kaiser, Diana V. Do +11
Medicine · #Retinal Diseases and Treatments #Retinal and Optic Conditions #Retinal Imaging and Analysis

paper · pdf · doi:10.1016/j.survophthal.2024.03.009

Citations

• Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
• Ranibizumab for Neovascular Age-Related Macular Degeneration
• Regulators, Pivotal Clinical Trials, and Drug Regulation in the Age of COVID-19